Monday, September 22, 2014
Inquirer Daily News

Softer sell by Big Pharma's sales reps, says WSJ

Cutbacks in sales forces and time-strapped doctors have drug companies altering how they pitch products, the Wall Street Journal reports.

Softer sell by Big Pharma's sales reps, says WSJ

Now that Alcoa has kicked off earnings season, we're in that quiet period before the onslaught later this month of numbers, justifications and "wait till next year." (Which would be this year.)

What caught my attention as I scanned the usual news outlets was this: The Wall Street Journal reports on how sales reps for the pharmaceutical industry have changed their sales pitches. Will the softer sell work? Here's a link to the story.

In other news, Shire PLC isn't providing any details, but the British drug company with North American headquarters in Wayne, Pa., said it has acquired the U.S. rights to Resolor, a constipation treatment, from Janssen Pharmaceutica N.V.

Also, no terms were released as Abry Partners, a private-equity firm, invested in Conshohocken-based NSM Insurance Group, a 21-year-old firm that focuses on niche insurance products. The capital will be used to support acquisition and growth plans, NSM said.

Mike Armstrong Inquirer Columnist
About this blog
Mike Armstrong blogs about Philadelphia corporations and business-related topics. Contact him at 215-854-2980. Reach Mike at marmstrong@phillynews.com.

Mike Armstrong Inquirer Columnist
Business Videos:
Also on Philly.com:
Stay Connected